Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma

Medical Mycology

Volumn 49, Issue 3, 2011, Pages 306-310

  Gabriel, F ^a,b   Noel, T ^b   Accoceberry, I ^a,b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

blood infection; molecular diagnosis; Trichosporon loubieri

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CEFTAZIDIME; DNA 18S; FLUCONAZOLE; FLUCYTOSINE; IMIPENEM; INTERNAL TRANSCRIBED SPACER; OFLOXACIN; POSACONAZOLE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UREASE; VALACICLOVIR; VANCOMYCIN; VORICONAZOLE;

ADENOSQUAMOUS CARCINOMA; ADULT; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLAST CELL; BLOOD CULTURE; BONE MARROW BIOPSY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; CORTICOSTEROID THERAPY; CRYPTOCOCCUS; CRYPTOCOCCUS HUMICOLA; CRYPTOCOCCUS LAURENTII; CULTURE MEDIUM; DISSEMINATED TRICHOSPORONOSIS; DRUG DOSE REDUCTION; EMPIRICISM; FEMALE; FEVER; FUNGAL STRAIN; GRAM NEGATIVE SEPSIS; HERPES ZOSTER; HUMAN; HUMAN TISSUE; LIVER DYSFUNCTION; LUNG ADENOCARCINOMA; LUNG DISEASE; LUNG LOBECTOMY; LUNG SQUAMOUS CELL CARCINOMA; LYMPHADENOPATHY; LYMPHOBLASTOMA; NEISSERIA MENINGITIDIS; NUCLEOTIDE SEQUENCE; PANCYTOPENIA; PERICARDITIS; PHARYNGITIS; RADIODENSITOMETRY; STRAIN IDENTIFICATION; TRICHOSPORON; TRICHOSPORON ASAHII; TRICHOSPORON INKIN; TRICHOSPORON LOUBIERI; TRICHOSPORON MUCOIDES; TRICHOSPORONOSIS;

ANTIFUNGAL AGENTS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FATAL OUTCOME; FEMALE; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR SEQUENCE DATA; MYCOSES; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIMIDINES; SEQUENCE ANALYSIS, DNA; TRIAZOLES; TRICHOSPORON; YOUNG ADULT;

TRICHOSPORON LOUBIERI;

EID: 79952687523     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.525758     Document Type: Article

References (27)

1. Guého E, Smith MT, Hoog GS, et al. Contributions to a revision of the genus Trichosporon. Antonie van Leeuwenhoek 1992; 61: 289-316.
2. Chagas-Neto T, Chaves G, Colombo A. Update on the genus Trichos-poron. Mycopathologia 2008; 166: 121-132.
3. Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (Suppl. 1): 48-66. (Pubitemid 38379951)
4. Rodrigues GDS, de Faria RRU, Guazzelli LS, Oliveira FDM, Severo LC. Nosocomial infection due to Trichosporon asahii: clinical revi-sion of 22 cases. Rev Iberoam Micol 2006; 23: 85-89 [in Spanish]. (Pubitemid 44133525)
5. Walsh TJ, Lee JW, Melcher GP, et al. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis 1992; 166: 121-133.
6. Krcmery Jr. V, Mateička F, Kunová A, et al. Hematogenous trichospo-ronosis in cancer patients: report of 12 cases including 5 during proph-ylaxis with itraconazole. Support Care Cancer 1999; 7: 39-43. (Pubitemid 29140174)
7. Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181-194. (Pubitemid 29123652)
8. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419-4431. (Pubitemid 39362350)
9. Castón-Osorio J, Rivero A, Torre-Cisneros J. Epidemiology of inva-sive fungal infection. Int J Antimicrob Agents 2008; 32 (Suppl. 2): S103-S109.
10. Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with he-matological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43: 1818-1828.
11. Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fun-gal pathogens. Infect Dis Clin North Am 2002; 16: 915-933, vi-vii. (Pubitemid 35477519)
12. Guého E, Smith MT, Hoog GS. Trichosporon Behrend. In: Kurtzman CP, Fell JW (eds). The Yeasts, a Taxonomic Study, 4th edn. Amsterdam: Elsevier, 1998: 854-872.
13. Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33: 2913-2919.
14. Einsele H, Hebart H, Roller G, et al. Detection and identif cation of fungal pathogens in blood by using molecular probes. J Clin Micro-biol 1997; 35: 1353-1360. (Pubitemid 27216794)
15. Marty FM, Barouch DH, Coakley EP, Baden LR. Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol 2003; 41: 5317-5320. (Pubitemid 37429970)
16. Zeng J, de Souza Motta C, Fukushima K, et al. Identif cation of Trichosporon spp. strains by sequencing D1/D2 region and sub-typing by sequencing ribosomal intergenic spacer region of ribosomal DNA. J Huazhong Univ Sci Technolog Med Sci 2009; 29: 655-658.
17. Altschul S, Madden T, Schaffer A, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997; 25: 3389-3402. (Pubitemid 27359211)
18. Padhye AA, Verghese S, Ravichandran P, et al. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol 2003; 41: 479-482. (Pubitemid 36098627)
19. Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Tricho-sporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol 1993; 5: 79-113.
20. Toriumi Y, Sugita T, Nakajima M, Matsushima T, Shinoda T. Anti-fungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology. Microbiol Immu-nol 2002; 46: 89-93. (Pubitemid 34194967)
21. Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fun-gal isolates: review of the literature. Rev Iberoam Micol 2003; 20: 121-136. (Pubitemid 38724618)
22. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, et al. In vitro an-tifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002; 46: 1144-1146. (Pubitemid 34260371)
23. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, et al. Suscepti-bility patterns and molecular identif cation of Trichosporon species. Antimicrob Agents Chemother 2005; 49: 4026-4034. (Pubitemid 41400942)
24. Walsh TJ, Melcher GP, Rinaldi MG, et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990; 28: 1616-1622. (Pubitemid 20212896)
25. Wolf DG, Falk R, Hacham M, et al. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2001; 39: 4420-4425. (Pubitemid 33117133)
26. Anaissie E, Gokaslan A, Hachem R, et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992; 15: 781-787.
27. Taj-Aldeen SJ, Al-Ansari N, El Shafei S, et al. Molecular identi-f cation and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol 2009; 47: 1791-1799.